Search Browse Earnings

Sionna Therapeutics, Inc. — SlamSEC

Sionna Therapeutics, Inc.

Nasdaq:SION

Pharmaceutical Preparations·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Cloonan Michael

Revenue

—

Adj. EBITDA

-$69.9M

FY 2025

Net Income

-$61.7M

FY 2025

EPS (Diluted)

-$15.99

FY 2025

Stock Price

$38.03

+5.9%

2026-03-10

52W Range

$7.25 – $45.00

P/E Ratio

-2.4x

Market Cap

$1.7B

Cash

$37.8M

FY 2025

Total Debt

—

Net Cash

$37.8M

Enterprise Value

$1.7B

Debt / EBITDA

0.5x

FY 2025

EV / EBITDA

-23.9x

Employees

—